5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Optimal administration of bronchodilators with valved holding chambers in preschool children: a review of literature

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Our aim was to synthesize the published literature on factors that potentially affect the delivery of bronchodilators using valved holding chambers (VHC) in preschool children. We also aimed to identify those attributes that are not yet incorporated or clearly stated in the guidelines and those topics that are still lacking sufficient data. There is strong evidence supporting several recommendations in current guidelines. Based on present knowledge, bronchodilators should be delivered by VHC administering each puff separately. Face mask should be omitted as soon as the child can hold the mouthpiece of the VHC tightly between the lips and teeth. Based on the review, we suggest adding a specific note to current guidelines about the effect of chamber volume and the impact of co-operation during drug administration. Calming the child and securing a tight face-to-mask seal is critical for successful drug delivery. There is not enough evidence to make specific recommendations on the most reliable VHC and face mask for children. There is an urgent need for studies that evaluate and compare the effectiveness of VHCs in various clinical settings in wide age-groups and respiratory patterns. In addition, there is insufficient data on ideal chamber volume, material, and effective antistatic treatment.

          What is Known:

          Valved holding chambers (VHC) should not be considered interchangeable when used with pressurized metered dose inhalers (pMDI) .

          Drug delivery is influenced by VHC volume, aerodynamic and electrostatic properties; mask fit; respiratory pattern and co-operation during inhalation; and the number of puffs actuated .

          What is New:

          The impact of co-operation, VHC volume, and good mask-to-face fit during drug inhalation is not stressed enough in the guidelines .

          Studies are urgently needed to evaluate the effectiveness of different VHCs in various clinical settings focusing on VHC electrostatic properties, respiratory patters, face masks, and ideal pMDI+VHC combinations .

          Related collections

          Most cited references50

          • Record: found
          • Abstract: found
          • Article: not found

          Global strategy for asthma management and prevention: GINA executive summary.

          Asthma is a serious health problem throughout the world. During the past two decades, many scientific advances have improved our understanding of asthma and ability to manage and control it effectively. However, recommendations for asthma care need to be adapted to local conditions, resources and services. Since it was formed in 1993, the Global Initiative for Asthma, a network of individuals, organisations and public health officials, has played a leading role in disseminating information about the care of patients with asthma based on a process of continuous review of published scientific investigations. A comprehensive workshop report entitled "A Global Strategy for Asthma Management and Prevention", first published in 1995, has been widely adopted, translated and reproduced, and forms the basis for many national guidelines. The 2006 report contains important new themes. First, it asserts that "it is reasonable to expect that in most patients with asthma, control of the disease can and should be achieved and maintained," and recommends a change in approach to asthma management, with asthma control, rather than asthma severity, being the focus of treatment decisions. The importance of the patient-care giver partnership and guided self-management, along with setting goals for treatment, are also emphasised.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Reducing Aerosol-Related Risk of Transmission in the Era of COVID-19: An Interim Guidance Endorsed by the International Society of Aerosols in Medicine

            National and international guidelines recommend droplet/airborne transmission and contact precautions for those caring for coronavirus disease 2019 (COVID-19) patients in ambulatory and acute care settings. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, an acute respiratory infectious agent, is primarily transmitted between people through respiratory droplets and contact routes. A recognized key to transmission of COVID-19, and droplet infections generally, is the dispersion of bioaerosols from the patient. Increased risk of transmission has been associated with aerosol generating procedures that include endotracheal intubation, bronchoscopy, open suctioning, administration of nebulized treatment, manual ventilation before intubation, turning the patient to the prone position, disconnecting the patient from the ventilator, noninvasive positive-pressure ventilation, tracheostomy, and cardiopulmonary resuscitation. The knowledge that COVID-19 subjects can be asymptomatic and still shed virus, producing infectious droplets during breathing, suggests that health care workers (HCWs) should assume every patient is potentially infectious during this pandemic. Taking actions to reduce risk of transmission to HCWs is, therefore, a vital consideration for safe delivery of all medical aerosols. Guidelines for use of personal protective equipment (glove, gowns, masks, shield, and/or powered air purifying respiratory) during high-risk procedures are essential and should be considered for use with lower risk procedures such as administration of uncontaminated medical aerosols. Bioaerosols generated by infected patients are a major source of transmission for SARS CoV-2, and other infectious agents. In contrast, therapeutic aerosols do not add to the risk of disease transmission unless contaminated by patients or HCWs.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma

              In acute asthma inhaled beta(2)-agonists are often administered by nebuliser to relieve bronchospasm, but some have argued that metered-dose inhalers with a holding chamber (spacer) can be equally effective. Nebulisers require a power source and need regular maintenance, and are more expensive in the community setting.
                Bookmark

                Author and article information

                Contributors
                peter.csonka@terveystalo.com
                terhi.tapiainen@oulu.fi
                mika.makela@hus.fi
                lauri.lehtimaki@tuni.fi
                Journal
                Eur J Pediatr
                Eur J Pediatr
                European Journal of Pediatrics
                Springer Berlin Heidelberg (Berlin/Heidelberg )
                0340-6199
                1432-1076
                20 April 2021
                20 April 2021
                : 1-9
                Affiliations
                [1 ]GRID grid.412330.7, ISNI 0000 0004 0628 2985, Centre for Child Health Research, , Tampere University and Tampere University Hospital, ; Kalevantie 4, 33014 Tampereen yliopisto, Tampere, Finland
                [2 ]Terveystalo Healthcare, Tampere, Finland
                [3 ]GRID grid.10858.34, ISNI 0000 0001 0941 4873, Department of Pediatrics and Adolescent Medicine, Oulu University Hospital and PEDEGO Research Unit, , University of Oulu, ; Oulu, Finland
                [4 ]GRID grid.15485.3d, ISNI 0000 0000 9950 5666, Skin and Allergy Hospital, , Helsinki University Hospital and University of Helsinki, ; Helsinki, Finland
                [5 ]GRID grid.412330.7, ISNI 0000 0004 0628 2985, Allergy Centre, , Tampere University Hospital, ; Tampere, Finland
                [6 ]GRID grid.502801.e, ISNI 0000 0001 2314 6254, Faculty of Medicine and Health Technology, , Tampere University, ; Tampere, Finland
                Author notes

                Communicated by Peter de Winter

                Author information
                http://orcid.org/0000-0003-0819-7875
                Article
                4074
                10.1007/s00431-021-04074-3
                8055476
                1e59a107-18c2-43b0-a371-ef0aea942f8e
                © The Author(s) 2021

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 18 January 2021
                : 6 March 2021
                : 8 April 2021
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/501100006706, Tampereen Tuberkuloosisäätiö;
                Funded by: FundRef http://dx.doi.org/10.13039/501100008309, Hengityssairauksien Tutkimussäätiö;
                Categories
                Review

                Pediatrics
                bronchodilators,valved holding chambers,preschool children,spacer,acute,management,asthma,wheezing,emergency treatment,inhalation therapy,guidelines,drug delivery

                Comments

                Comment on this article